Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZFAND2A pseudogene 2 (abbreviated as ZFAND2AP2) is annotated as a pseudogene on chromosome 14 in the human genome, with NCBI Gene ID 127379733 and Ensembl ID ENSG00000275002. It is named for its sequence similarity to the functional gene ZFAND2A (zinc finger, AN1-type domain 2A), but ZFAND2AP2 itself is not protein-coding and is annotated as a nonfunctional gene duplicate, or “molecular fossil”. Pseudogenes like ZFAND2AP2 are typically noncoding due to disablements such as premature stop codons or frameshifts and are generally not considered therapeutic targets because they do not produce an active molecule that can be modulated by drugs. There is no evidence that ZFAND2AP2 is transcribed, translated, or has any regulatory function, nor is it associated with any known diseases or drugs. In summary, ZFAND2A pseudogene 2 is a nonfunctional DNA sequence related by similarity to ZFAND2A, but it does not serve as a molecular target or protein of therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZFAND2A pseudogene 2 (ZFAND2AP2).